From Gut to Brain: A New Frontier in Parkinson’s Therapy - Anumantha Kanthasamy project скачать в хорошем качестве

From Gut to Brain: A New Frontier in Parkinson’s Therapy - Anumantha Kanthasamy project

Could the gut microbiome help transform Parkinson’s treatment? Researchers at the University of Georgia’s Isakson Center for Neurological Disease Research are investigating how gut inflammation, microbiome imbalance, and increased intestinal permeability may contribute to Parkinson’s and Crohn’s disease. They have developed an engineered probiotic called the Levodopa Bacterial Live Biotherapeutic that temporarily resides in the gut and continuously releases L DOPA. The goal is smoother symptom control, fewer treatment fluctuations, and improved gut health. By combining synthetic biology with artificial intelligence to identify new therapeutic enzymes, the team is advancing a precision medicine approach that harnesses the microbiome to deliver targeted, continuous therapies for neurological and gastrointestinal diseases. #Parkinsons #Microbiome #GutBrainAxis #Biotechnology #PrecisionMedicine